Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States Article Swipe
Robertino M. Mera
,
Susan Scheer
,
Christoph C Carter
,
Moupali Das
,
Julius Asubonteng
,
Scott McCallister
,
Jared M. Baeten
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1002/jia2.25433
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1002/jia2.25433
Introduction New HIV diagnoses have fallen in the past decade due to increased HIV testing, earlier diagnosis, earlier antiretroviral treatment, improved linkage to care and engagement in care, and the recent increased uptake of pre‐exposure prophylaxis (PrEP). We propose a novel method to compute the rate of new HIV diagnoses at the Metropolitan Statistical Area (MSA) level in the US to support the evaluation of comprehensive treatment and prevention efforts over time. Methods The number of new HIV diagnoses, number of individuals with a PrEP indication and aggregated person‐time exposed to PrEP during the years 2012 to 2017 were used to compute a new HIV diagnosis rate for people at risk of HIV excluding those already on PrEP for the 105 MSAs in the US with published HIV surveillance data. In our calculation of person‐time with a PrEP indication, time‐at‐risk excluded time on PrEP and time after an HIV diagnosis. We used a multivariate Poisson regression model to estimate HIV diagnosis rates by year and location. Results From 2012 to 2017, the aggregate HIV diagnoses rate among high‐risk individuals with an indication for PrEP in the 105 MSAs decreased from 4.14 per 100 person‐years (PY) (95% CI 4.10 to 4.19) to 3.26 per 100 PY (95% CI 3.22 to 3.30). For the 25 US MSAs that overlapped with an ongoing large randomized clinical trial of PrEP in men who have sex with men (MSM), the HIV diagnosis rate from 2012 to 2017 decreased from 4.86 per 100 PY (95% CI 4.80 to 4.93) to 3.61 per 100 PY (95% CI 3.56 to 3.66), a decline that was more rapid than in non‐study MSAs (IRR for trial site 1.19, 95% CI 1.18 to 1.20). Conclusions We propose a model to estimate the background HIV diagnosis rate in people at risk for HIV and with a PrEP indication in US MSAs (excluding those on PrEP) using publically available surveillance data which can evaluate trends over time. Data generated using this methodology could be used by policy makers and local HIV prevention specialists to evaluate and monitor their prevention efforts for the population at risk in their communities.
Related Topics
Concepts
Medicine
Pre-exposure prophylaxis
Medical diagnosis
Poisson regression
Treatment as prevention
Human immunodeficiency virus (HIV)
Men who have sex with men
Demography
HIV diagnosis
Family medicine
Antiretroviral therapy
Population
Environmental health
Viral load
Syphilis
Pathology
Sociology
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/jia2.25433
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433
- OA Status
- gold
- Cited By
- 10
- References
- 10
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2996643654
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2996643654Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/jia2.25433Digital Object Identifier
- Title
-
Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United StatesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-12-01Full publication date if available
- Authors
-
Robertino M. Mera, Susan Scheer, Christoph C Carter, Moupali Das, Julius Asubonteng, Scott McCallister, Jared M. BaetenList of authors in order
- Landing page
-
https://doi.org/10.1002/jia2.25433Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433Direct OA link when available
- Concepts
-
Medicine, Pre-exposure prophylaxis, Medical diagnosis, Poisson regression, Treatment as prevention, Human immunodeficiency virus (HIV), Men who have sex with men, Demography, HIV diagnosis, Family medicine, Antiretroviral therapy, Population, Environmental health, Viral load, Syphilis, Pathology, SociologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
10Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2023: 1, 2022: 4, 2021: 2, 2020: 2Per-year citation counts (last 5 years)
- References (count)
-
10Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2996643654 |
|---|---|
| doi | https://doi.org/10.1002/jia2.25433 |
| ids.doi | https://doi.org/10.1002/jia2.25433 |
| ids.mag | 2996643654 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31860171 |
| ids.openalex | https://openalex.org/W2996643654 |
| fwci | 1.35076306 |
| mesh[0].qualifier_ui | Q000175 |
| mesh[0].descriptor_ui | D015658 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | diagnosis |
| mesh[0].descriptor_name | HIV Infections |
| mesh[1].qualifier_ui | Q000453 |
| mesh[1].descriptor_ui | D015658 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | epidemiology |
| mesh[1].descriptor_name | HIV Infections |
| mesh[2].qualifier_ui | Q000517 |
| mesh[2].descriptor_ui | D015658 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | prevention & control |
| mesh[2].descriptor_name | HIV Infections |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D018451 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Homosexuality, Male |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008297 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Male |
| mesh[6].qualifier_ui | Q000379 |
| mesh[6].descriptor_ui | D065129 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | methods |
| mesh[6].descriptor_name | Pre-Exposure Prophylaxis |
| mesh[7].qualifier_ui | Q000453 |
| mesh[7].descriptor_ui | D014481 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | epidemiology |
| mesh[7].descriptor_name | United States |
| mesh[8].qualifier_ui | Q000175 |
| mesh[8].descriptor_ui | D015658 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | diagnosis |
| mesh[8].descriptor_name | HIV Infections |
| mesh[9].qualifier_ui | Q000453 |
| mesh[9].descriptor_ui | D015658 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | epidemiology |
| mesh[9].descriptor_name | HIV Infections |
| mesh[10].qualifier_ui | Q000517 |
| mesh[10].descriptor_ui | D015658 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | prevention & control |
| mesh[10].descriptor_name | HIV Infections |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D018451 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Homosexuality, Male |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008297 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Male |
| mesh[14].qualifier_ui | Q000379 |
| mesh[14].descriptor_ui | D065129 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | methods |
| mesh[14].descriptor_name | Pre-Exposure Prophylaxis |
| mesh[15].qualifier_ui | Q000453 |
| mesh[15].descriptor_ui | D014481 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | epidemiology |
| mesh[15].descriptor_name | United States |
| type | article |
| title | Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States |
| biblio.issue | 12 |
| biblio.volume | 22 |
| biblio.last_page | e25433 |
| biblio.first_page | e25433 |
| topics[0].id | https://openalex.org/T10082 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | HIV/AIDS Research and Interventions |
| topics[1].id | https://openalex.org/T11860 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9990000128746033 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | HIV, Drug Use, Sexual Risk |
| topics[2].id | https://openalex.org/T10112 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9970999956130981 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2406 |
| topics[2].subfield.display_name | Virology |
| topics[2].display_name | HIV Research and Treatment |
| funders[0].id | https://openalex.org/F4320308573 |
| funders[0].ror | https://ror.org/056546b03 |
| funders[0].display_name | Gilead Sciences |
| is_xpac | False |
| apc_list.value | 2400 |
| apc_list.currency | USD |
| apc_list.value_usd | 2400 |
| apc_paid.value | 2400 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2400 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8926371335983276 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779496540 |
| concepts[1].level | 5 |
| concepts[1].score | 0.767734169960022 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7239230 |
| concepts[1].display_name | Pre-exposure prophylaxis |
| concepts[2].id | https://openalex.org/C534262118 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6578119993209839 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q177719 |
| concepts[2].display_name | Medical diagnosis |
| concepts[3].id | https://openalex.org/C73269764 |
| concepts[3].level | 3 |
| concepts[3].score | 0.580620527267456 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q954529 |
| concepts[3].display_name | Poisson regression |
| concepts[4].id | https://openalex.org/C2777931914 |
| concepts[4].level | 5 |
| concepts[4].score | 0.5462061166763306 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q24975420 |
| concepts[4].display_name | Treatment as prevention |
| concepts[5].id | https://openalex.org/C3013748606 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5281569957733154 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[5].display_name | Human immunodeficiency virus (HIV) |
| concepts[6].id | https://openalex.org/C2776939746 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5172649025917053 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q853451 |
| concepts[6].display_name | Men who have sex with men |
| concepts[7].id | https://openalex.org/C149923435 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4713071286678314 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q37732 |
| concepts[7].display_name | Demography |
| concepts[8].id | https://openalex.org/C2910823671 |
| concepts[8].level | 5 |
| concepts[8].score | 0.43899139761924744 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q337517 |
| concepts[8].display_name | HIV diagnosis |
| concepts[9].id | https://openalex.org/C512399662 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3406209945678711 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[9].display_name | Family medicine |
| concepts[10].id | https://openalex.org/C2993143319 |
| concepts[10].level | 4 |
| concepts[10].score | 0.24376022815704346 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[10].display_name | Antiretroviral therapy |
| concepts[11].id | https://openalex.org/C2908647359 |
| concepts[11].level | 2 |
| concepts[11].score | 0.20903369784355164 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[11].display_name | Population |
| concepts[12].id | https://openalex.org/C99454951 |
| concepts[12].level | 1 |
| concepts[12].score | 0.19490715861320496 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[12].display_name | Environmental health |
| concepts[13].id | https://openalex.org/C142462285 |
| concepts[13].level | 3 |
| concepts[13].score | 0.18644344806671143 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[13].display_name | Viral load |
| concepts[14].id | https://openalex.org/C2776983459 |
| concepts[14].level | 3 |
| concepts[14].score | 0.09373244643211365 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q41083 |
| concepts[14].display_name | Syphilis |
| concepts[15].id | https://openalex.org/C142724271 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[15].display_name | Pathology |
| concepts[16].id | https://openalex.org/C144024400 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q21201 |
| concepts[16].display_name | Sociology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8926371335983276 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/pre-exposure-prophylaxis |
| keywords[1].score | 0.767734169960022 |
| keywords[1].display_name | Pre-exposure prophylaxis |
| keywords[2].id | https://openalex.org/keywords/medical-diagnosis |
| keywords[2].score | 0.6578119993209839 |
| keywords[2].display_name | Medical diagnosis |
| keywords[3].id | https://openalex.org/keywords/poisson-regression |
| keywords[3].score | 0.580620527267456 |
| keywords[3].display_name | Poisson regression |
| keywords[4].id | https://openalex.org/keywords/treatment-as-prevention |
| keywords[4].score | 0.5462061166763306 |
| keywords[4].display_name | Treatment as prevention |
| keywords[5].id | https://openalex.org/keywords/human-immunodeficiency-virus |
| keywords[5].score | 0.5281569957733154 |
| keywords[5].display_name | Human immunodeficiency virus (HIV) |
| keywords[6].id | https://openalex.org/keywords/men-who-have-sex-with-men |
| keywords[6].score | 0.5172649025917053 |
| keywords[6].display_name | Men who have sex with men |
| keywords[7].id | https://openalex.org/keywords/demography |
| keywords[7].score | 0.4713071286678314 |
| keywords[7].display_name | Demography |
| keywords[8].id | https://openalex.org/keywords/hiv-diagnosis |
| keywords[8].score | 0.43899139761924744 |
| keywords[8].display_name | HIV diagnosis |
| keywords[9].id | https://openalex.org/keywords/family-medicine |
| keywords[9].score | 0.3406209945678711 |
| keywords[9].display_name | Family medicine |
| keywords[10].id | https://openalex.org/keywords/antiretroviral-therapy |
| keywords[10].score | 0.24376022815704346 |
| keywords[10].display_name | Antiretroviral therapy |
| keywords[11].id | https://openalex.org/keywords/population |
| keywords[11].score | 0.20903369784355164 |
| keywords[11].display_name | Population |
| keywords[12].id | https://openalex.org/keywords/environmental-health |
| keywords[12].score | 0.19490715861320496 |
| keywords[12].display_name | Environmental health |
| keywords[13].id | https://openalex.org/keywords/viral-load |
| keywords[13].score | 0.18644344806671143 |
| keywords[13].display_name | Viral load |
| keywords[14].id | https://openalex.org/keywords/syphilis |
| keywords[14].score | 0.09373244643211365 |
| keywords[14].display_name | Syphilis |
| language | en |
| locations[0].id | doi:10.1002/jia2.25433 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S66330005 |
| locations[0].source.issn | 1758-2652 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1758-2652 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of the International AIDS Society |
| locations[0].source.host_organization | https://openalex.org/P4310320728 |
| locations[0].source.host_organization_name | International AIDS Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320728 |
| locations[0].source.host_organization_lineage_names | International AIDS Society |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of the International AIDS Society |
| locations[0].landing_page_url | https://doi.org/10.1002/jia2.25433 |
| locations[1].id | pmid:31860171 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of the International AIDS Society |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31860171 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7086379 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Int AIDS Soc |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7086379 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5046085102 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1701-560X |
| authorships[0].author.display_name | Robertino M. Mera |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210140816 |
| authorships[0].affiliations[0].raw_affiliation_string | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210140816 |
| authorships[0].institutions[0].ror | https://ror.org/056546b03 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210140816 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Gilead Sciences (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Robertino Mera |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[1].author.id | https://openalex.org/A5049977096 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-1060-3027 |
| authorships[1].author.display_name | Susan Scheer |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210100173 |
| authorships[1].affiliations[0].raw_affiliation_string | San Francisco Department of Public Health, San Francisco, CA, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210100173 |
| authorships[1].institutions[0].ror | https://ror.org/017ztfb41 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210100173 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | San Francisco Department of Public Health |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Susan Scheer |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | San Francisco Department of Public Health, San Francisco, CA, USA |
| authorships[2].author.id | https://openalex.org/A5073519594 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7793-8011 |
| authorships[2].author.display_name | Christoph C Carter |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210140816 |
| authorships[2].affiliations[0].raw_affiliation_string | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210140816 |
| authorships[2].institutions[0].ror | https://ror.org/056546b03 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210140816 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Gilead Sciences (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Christoph Carter |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[3].author.id | https://openalex.org/A5076529428 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5034-8185 |
| authorships[3].author.display_name | Moupali Das |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210140816 |
| authorships[3].affiliations[0].raw_affiliation_string | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210140816 |
| authorships[3].institutions[0].ror | https://ror.org/056546b03 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210140816 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Gilead Sciences (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Moupali Das |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[4].author.id | https://openalex.org/A5077499177 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8991-3276 |
| authorships[4].author.display_name | Julius Asubonteng |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210140816 |
| authorships[4].affiliations[0].raw_affiliation_string | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210140816 |
| authorships[4].institutions[0].ror | https://ror.org/056546b03 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210140816 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Gilead Sciences (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Julius Asubonteng |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[5].author.id | https://openalex.org/A5033836920 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2536-3188 |
| authorships[5].author.display_name | Scott McCallister |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210140816 |
| authorships[5].affiliations[0].raw_affiliation_string | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210140816 |
| authorships[5].institutions[0].ror | https://ror.org/056546b03 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210140816 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Gilead Sciences (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Scott McCallister |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Gilead Sciences, Inc, Foster City, CA, USA |
| authorships[6].author.id | https://openalex.org/A5064486492 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8242-8438 |
| authorships[6].author.display_name | Jared M. Baeten |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I201448701 |
| authorships[6].affiliations[0].raw_affiliation_string | Departments of Global Health, Medicine and Epidemiology, University of Washington, Seattle, WA, USA |
| authorships[6].institutions[0].id | https://openalex.org/I201448701 |
| authorships[6].institutions[0].ror | https://ror.org/00cvxb145 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I201448701 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | University of Washington |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Jared Baeten |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Departments of Global Health, Medicine and Epidemiology, University of Washington, Seattle, WA, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10082 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | HIV/AIDS Research and Interventions |
| related_works | https://openalex.org/W2756144476, https://openalex.org/W2808761516, https://openalex.org/W3039191001, https://openalex.org/W3210535956, https://openalex.org/W2004688271, https://openalex.org/W2802699289, https://openalex.org/W2605835179, https://openalex.org/W4200002368, https://openalex.org/W2518482422, https://openalex.org/W2325717071 |
| cited_by_count | 10 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 2 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/jia2.25433 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S66330005 |
| best_oa_location.source.issn | 1758-2652 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1758-2652 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of the International AIDS Society |
| best_oa_location.source.host_organization | https://openalex.org/P4310320728 |
| best_oa_location.source.host_organization_name | International AIDS Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320728 |
| best_oa_location.source.host_organization_lineage_names | International AIDS Society |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of the International AIDS Society |
| best_oa_location.landing_page_url | https://doi.org/10.1002/jia2.25433 |
| primary_location.id | doi:10.1002/jia2.25433 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S66330005 |
| primary_location.source.issn | 1758-2652 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1758-2652 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of the International AIDS Society |
| primary_location.source.host_organization | https://openalex.org/P4310320728 |
| primary_location.source.host_organization_name | International AIDS Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320728 |
| primary_location.source.host_organization_lineage_names | International AIDS Society |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25433 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of the International AIDS Society |
| primary_location.landing_page_url | https://doi.org/10.1002/jia2.25433 |
| publication_date | 2019-12-01 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2117057469, https://openalex.org/W2103920597, https://openalex.org/W2157417559, https://openalex.org/W2896818093, https://openalex.org/W2600060125, https://openalex.org/W2414118672, https://openalex.org/W2415561974, https://openalex.org/W2761854305, https://openalex.org/W2600358701, https://openalex.org/W2505200026 |
| referenced_works_count | 10 |
| abstract_inverted_index.a | 40, 84, 103, 137, 153, 264, 287, 304 |
| abstract_inverted_index.25 | 213 |
| abstract_inverted_index.CI | 197, 207, 250, 260, 280 |
| abstract_inverted_index.In | 131 |
| abstract_inverted_index.PY | 205, 248, 258 |
| abstract_inverted_index.US | 60, 125, 214, 308 |
| abstract_inverted_index.We | 38, 151, 285 |
| abstract_inverted_index.an | 148, 181, 219 |
| abstract_inverted_index.at | 51, 110, 298, 351 |
| abstract_inverted_index.be | 331 |
| abstract_inverted_index.by | 163, 333 |
| abstract_inverted_index.in | 7, 27, 58, 123, 185, 227, 271, 296, 307, 353 |
| abstract_inverted_index.of | 34, 47, 65, 76, 81, 112, 134, 225 |
| abstract_inverted_index.on | 117, 143, 312 |
| abstract_inverted_index.to | 12, 23, 43, 61, 91, 97, 101, 158, 170, 199, 201, 209, 241, 252, 254, 262, 282, 289, 341 |
| abstract_inverted_index.100 | 193, 204, 247, 257 |
| abstract_inverted_index.105 | 121, 187 |
| abstract_inverted_index.95% | 279 |
| abstract_inverted_index.For | 211 |
| abstract_inverted_index.HIV | 3, 14, 49, 78, 105, 113, 128, 149, 160, 174, 236, 293, 301, 338 |
| abstract_inverted_index.New | 2 |
| abstract_inverted_index.The | 74 |
| abstract_inverted_index.and | 25, 29, 68, 87, 145, 165, 302, 336, 343 |
| abstract_inverted_index.can | 320 |
| abstract_inverted_index.due | 11 |
| abstract_inverted_index.for | 108, 119, 183, 275, 300, 348 |
| abstract_inverted_index.men | 228, 233 |
| abstract_inverted_index.new | 48, 77, 104 |
| abstract_inverted_index.our | 132 |
| abstract_inverted_index.per | 192, 203, 246, 256 |
| abstract_inverted_index.sex | 231 |
| abstract_inverted_index.the | 8, 30, 45, 52, 59, 63, 94, 120, 124, 172, 186, 212, 235, 291, 349 |
| abstract_inverted_index.was | 267 |
| abstract_inverted_index.who | 229 |
| abstract_inverted_index.(95% | 196, 206, 249, 259 |
| abstract_inverted_index.(IRR | 274 |
| abstract_inverted_index.(PY) | 195 |
| abstract_inverted_index.1.18 | 281 |
| abstract_inverted_index.2012 | 96, 169, 240 |
| abstract_inverted_index.2017 | 98, 242 |
| abstract_inverted_index.3.22 | 208 |
| abstract_inverted_index.3.26 | 202 |
| abstract_inverted_index.3.56 | 261 |
| abstract_inverted_index.3.61 | 255 |
| abstract_inverted_index.4.10 | 198 |
| abstract_inverted_index.4.14 | 191 |
| abstract_inverted_index.4.80 | 251 |
| abstract_inverted_index.4.86 | 245 |
| abstract_inverted_index.Area | 55 |
| abstract_inverted_index.Data | 325 |
| abstract_inverted_index.From | 168 |
| abstract_inverted_index.MSAs | 122, 188, 215, 273, 309 |
| abstract_inverted_index.PrEP | 85, 92, 118, 138, 144, 184, 226, 305 |
| abstract_inverted_index.care | 24 |
| abstract_inverted_index.data | 318 |
| abstract_inverted_index.from | 190, 239, 244 |
| abstract_inverted_index.have | 5, 230 |
| abstract_inverted_index.more | 268 |
| abstract_inverted_index.over | 71, 323 |
| abstract_inverted_index.past | 9 |
| abstract_inverted_index.rate | 46, 107, 176, 238, 295 |
| abstract_inverted_index.risk | 111, 299, 352 |
| abstract_inverted_index.site | 277 |
| abstract_inverted_index.than | 270 |
| abstract_inverted_index.that | 216, 266 |
| abstract_inverted_index.this | 328 |
| abstract_inverted_index.time | 142, 146 |
| abstract_inverted_index.used | 100, 152, 332 |
| abstract_inverted_index.were | 99 |
| abstract_inverted_index.with | 83, 126, 136, 180, 218, 232, 303 |
| abstract_inverted_index.year | 164 |
| abstract_inverted_index.(MSA) | 56 |
| abstract_inverted_index.1.19, | 278 |
| abstract_inverted_index.2017, | 171 |
| abstract_inverted_index.4.19) | 200 |
| abstract_inverted_index.4.93) | 253 |
| abstract_inverted_index.PrEP) | 313 |
| abstract_inverted_index.after | 147 |
| abstract_inverted_index.among | 177 |
| abstract_inverted_index.care, | 28 |
| abstract_inverted_index.could | 330 |
| abstract_inverted_index.data. | 130 |
| abstract_inverted_index.large | 221 |
| abstract_inverted_index.level | 57 |
| abstract_inverted_index.local | 337 |
| abstract_inverted_index.model | 157, 288 |
| abstract_inverted_index.novel | 41 |
| abstract_inverted_index.rapid | 269 |
| abstract_inverted_index.rates | 162 |
| abstract_inverted_index.their | 345, 354 |
| abstract_inverted_index.those | 115, 311 |
| abstract_inverted_index.time. | 72, 324 |
| abstract_inverted_index.trial | 224, 276 |
| abstract_inverted_index.using | 314, 327 |
| abstract_inverted_index.which | 319 |
| abstract_inverted_index.years | 95 |
| abstract_inverted_index.(MSM), | 234 |
| abstract_inverted_index.1.20). | 283 |
| abstract_inverted_index.3.30). | 210 |
| abstract_inverted_index.3.66), | 263 |
| abstract_inverted_index.decade | 10 |
| abstract_inverted_index.during | 93 |
| abstract_inverted_index.fallen | 6 |
| abstract_inverted_index.makers | 335 |
| abstract_inverted_index.method | 42 |
| abstract_inverted_index.number | 75, 80 |
| abstract_inverted_index.people | 109, 297 |
| abstract_inverted_index.policy | 334 |
| abstract_inverted_index.recent | 31 |
| abstract_inverted_index.trends | 322 |
| abstract_inverted_index.uptake | 33 |
| abstract_inverted_index.(PrEP). | 37 |
| abstract_inverted_index.Methods | 73 |
| abstract_inverted_index.Poisson | 155 |
| abstract_inverted_index.Results | 167 |
| abstract_inverted_index.already | 116 |
| abstract_inverted_index.compute | 44, 102 |
| abstract_inverted_index.decline | 265 |
| abstract_inverted_index.earlier | 16, 18 |
| abstract_inverted_index.efforts | 70, 347 |
| abstract_inverted_index.exposed | 90 |
| abstract_inverted_index.linkage | 22 |
| abstract_inverted_index.monitor | 344 |
| abstract_inverted_index.ongoing | 220 |
| abstract_inverted_index.propose | 39, 286 |
| abstract_inverted_index.support | 62 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.clinical | 223 |
| abstract_inverted_index.estimate | 159, 290 |
| abstract_inverted_index.evaluate | 321, 342 |
| abstract_inverted_index.excluded | 141 |
| abstract_inverted_index.improved | 21 |
| abstract_inverted_index.testing, | 15 |
| abstract_inverted_index.aggregate | 173 |
| abstract_inverted_index.available | 316 |
| abstract_inverted_index.decreased | 189, 243 |
| abstract_inverted_index.diagnoses | 4, 50, 175 |
| abstract_inverted_index.diagnosis | 106, 161, 237, 294 |
| abstract_inverted_index.excluding | 114 |
| abstract_inverted_index.generated | 326 |
| abstract_inverted_index.increased | 13, 32 |
| abstract_inverted_index.location. | 166 |
| abstract_inverted_index.published | 127 |
| abstract_inverted_index.treatment | 67 |
| abstract_inverted_index.(excluding | 310 |
| abstract_inverted_index.aggregated | 88 |
| abstract_inverted_index.background | 292 |
| abstract_inverted_index.diagnoses, | 79 |
| abstract_inverted_index.diagnosis, | 17 |
| abstract_inverted_index.diagnosis. | 150 |
| abstract_inverted_index.engagement | 26 |
| abstract_inverted_index.evaluation | 64 |
| abstract_inverted_index.indication | 86, 182, 306 |
| abstract_inverted_index.overlapped | 217 |
| abstract_inverted_index.population | 350 |
| abstract_inverted_index.prevention | 69, 339, 346 |
| abstract_inverted_index.publically | 315 |
| abstract_inverted_index.randomized | 222 |
| abstract_inverted_index.regression | 156 |
| abstract_inverted_index.treatment, | 20 |
| abstract_inverted_index.Conclusions | 284 |
| abstract_inverted_index.Statistical | 54 |
| abstract_inverted_index.calculation | 133 |
| abstract_inverted_index.high‐risk | 178 |
| abstract_inverted_index.indication, | 139 |
| abstract_inverted_index.individuals | 82, 179 |
| abstract_inverted_index.methodology | 329 |
| abstract_inverted_index.non‐study | 272 |
| abstract_inverted_index.prophylaxis | 36 |
| abstract_inverted_index.specialists | 340 |
| abstract_inverted_index.Introduction | 1 |
| abstract_inverted_index.Metropolitan | 53 |
| abstract_inverted_index.communities. | 355 |
| abstract_inverted_index.multivariate | 154 |
| abstract_inverted_index.surveillance | 129, 317 |
| abstract_inverted_index.comprehensive | 66 |
| abstract_inverted_index.person‐time | 89, 135 |
| abstract_inverted_index.antiretroviral | 19 |
| abstract_inverted_index.person‐years | 194 |
| abstract_inverted_index.pre‐exposure | 35 |
| abstract_inverted_index.time‐at‐risk | 140 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5033836920 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I4210140816 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.78709383 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |